These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 33144847)

  • 1. Evaluating the Relationship of GDF-15 with Clinical Characteristics, Cardinal Features, and Survival in Multiple Myeloma.
    Banaszkiewicz M; Małyszko J; Batko K; Koc-Żórawska E; Żórawski M; Dumnicka P; Jurczyszyn A; Woziwodzka K; Tisończyk J; Krzanowski M; Małyszko J; Waszczuk-Gajda A; Drożdż R; Kuźniewski M; Krzanowska K
    Mediators Inflamm; 2020; 2020():5657864. PubMed ID: 33144847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of hepcidin through GDF-15 in cancer-related anemia.
    Jiang F; Yu WJ; Wang XH; Tang YT; Guo L; Jiao XY
    Clin Chim Acta; 2014 Jan; 428():14-9. PubMed ID: 24384540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophil Gelatinase--Associated Lipocalin and Cystatin C Are Sensitive Markers of Renal Injury in Patients With Multiple Myeloma.
    Papassotiriou GP; Kastritis E; Gkotzamanidou M; Christoulas D; Eleutherakis-Papaiakovou E; Migkou M; Gavriatopoulou M; Roussou M; Margeli A; Papassotiriou I; Dimopoulos MA; Terpos E
    Clin Lymphoma Myeloma Leuk; 2016 Jan; 16(1):29-35. PubMed ID: 26632077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum Hepcidin and GDF-15 levels as prognostic markers in urothelial carcinoma of the upper urinary tract and renal cell carcinoma.
    Traeger L; Ellermann I; Wiethoff H; Ihbe J; Gallitz I; Eveslage M; Moritz R; Herrmann E; Schrader AJ; Steinbicker AU
    BMC Cancer; 2019 Jan; 19(1):74. PubMed ID: 30646851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor 15 increased in severe aplastic anemia patients.
    Shao Y; Wang H; Liu C; Cao Q; Fu R; Wang H; Wang T; Qi W; Shao Z
    Hematology; 2017 Oct; 22(9):548-553. PubMed ID: 28385068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythropoiesis-driven regulation of hepcidin in human red cell disorders is better reflected through concentrations of soluble transferrin receptor rather than growth differentiation factor 15.
    Fertrin KY; Lanaro C; Franco-Penteado CF; de Albuquerque DM; de Mello MR; Pallis FR; Bezerra MA; Hatzlhofer BL; Olbina G; Saad ST; da Silva Araújo A; Westerman M; Costa FF
    Am J Hematol; 2014 Apr; 89(4):385-90. PubMed ID: 24860871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum growth differentiation factor 15 levels in newly diagnosed multiple myeloma patients.
    Tarkun P; Birtas Atesoglu E; Mehtap O; Musul MM; Hacihanefioglu A
    Acta Haematol; 2014; 131(3):173-8. PubMed ID: 24216602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Growth Differentiation Factor-15 (GDF-15) levels are increased in patients with compound heterozygous sickle cell and beta-thalassemia (HbS/β
    Larissi K; Politou M; Margeli A; Poziopoulos C; Flevari P; Terpos E; Papassotiriou I; Voskaridou E
    Blood Cells Mol Dis; 2019 Jul; 77():137-141. PubMed ID: 31071550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GDF-15 and Hepcidin Levels in Nonanemic Patients with Impaired Glucose Tolerance.
    Yalcin MM; Altinova AE; Akturk M; Gulbahar O; Arslan E; Ors Sendogan D; Yetkin I; Toruner FB
    J Diabetes Res; 2016; 2016():1240843. PubMed ID: 27642607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure.
    Kempf T; von Haehling S; Peter T; Allhoff T; Cicoira M; Doehner W; Ponikowski P; Filippatos GS; Rozentryt P; Drexler H; Anker SD; Wollert KC
    J Am Coll Cardiol; 2007 Sep; 50(11):1054-60. PubMed ID: 17825714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutrophil gelatinase-associated lipocalin as a biomarker of renal impairment in patients with multiple myeloma.
    Chae H; Ryu H; Cha K; Kim M; Kim Y; Min CK
    Clin Lymphoma Myeloma Leuk; 2015 Jan; 15(1):35-40. PubMed ID: 25204517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth Differentiation Factor-15 as a Predictor of Idiopathic Membranous Nephropathy Progression: A Retrospective Study.
    Ham YR; Song CH; Bae HJ; Jeong JY; Yeo MK; Choi DE; Na KR; Lee KW
    Dis Markers; 2018; 2018():1463940. PubMed ID: 29682097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth differentiation factor 15, a marker of lung involvement in systemic sclerosis, is involved in fibrosis development but is not indispensable for fibrosis development.
    Lambrecht S; Smith V; De Wilde K; Coudenys J; Decuman S; Deforce D; De Keyser F; Elewaut D
    Arthritis Rheumatol; 2014 Feb; 66(2):418-27. PubMed ID: 24504814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and clinical role of growth differentiation factor-15 in ovarian carcinoma effusions.
    Bock AJ; Stavnes HT; Kempf T; Tropè CG; Berner A; Davidson B; Staff AC
    Int J Gynecol Cancer; 2010 Dec; 20(9):1448-55. PubMed ID: 21336029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth differentiation factor GDF-15 does not influence iron metabolism in stable chronic haemodialysis patients.
    Li XY; Ying J; Li JH; Zhu SL; Li J; Pai P
    Ann Clin Biochem; 2015 May; 52(Pt 3):399-403. PubMed ID: 25178559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth differentiation factor-15 in young sickle cell disease patients: relation to hemolysis, iron overload and vascular complications.
    Tantawy AA; Adly AA; Ismail EA; Darwish YW; Ali Zedan M
    Blood Cells Mol Dis; 2014 Dec; 53(4):189-93. PubMed ID: 25065856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioactivity and prognostic significance of growth differentiation factor GDF15 secreted by bone marrow mesenchymal stem cells in multiple myeloma.
    Corre J; Labat E; Espagnolle N; Hébraud B; Avet-Loiseau H; Roussel M; Huynh A; Gadelorge M; Cordelier P; Klein B; Moreau P; Facon T; Fournié JJ; Attal M; Bourin P
    Cancer Res; 2012 Mar; 72(6):1395-406. PubMed ID: 22301101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The multiple facets of the TGF-β family cytokine growth/differentiation factor-15/macrophage inhibitory cytokine-1.
    Unsicker K; Spittau B; Krieglstein K
    Cytokine Growth Factor Rev; 2013 Aug; 24(4):373-84. PubMed ID: 23787157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary NGAL for the diagnosis of the renal injury from multiple myeloma.
    Du W; Shen T; Li H; Liu Y; He L; Tan L; Hu M
    Cancer Biomark; 2017; 18(1):41-46. PubMed ID: 27814274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GDF-15 negatively regulates excess erythropoiesis and its overexpression is involved in erythroid hyperplasia.
    Ranjbaran R; Abbasi M; Rahimian E; Dehbidi GR; Seyyedi N; Zare F; Behzad-Behbahani A
    Exp Cell Res; 2020 Dec; 397(2):112346. PubMed ID: 33164866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.